Structural and Molecular Basis for Mitochondrial DNA Replication and Transcription in Health and Antiviral Drug Toxicity

Human mitochondrial DNA (mtDNA) is a 16.9 kbp double-stranded, circular DNA, encoding subunits of the oxidative phosphorylation electron transfer chain and essential RNAs for mitochondrial protein translation. The minimal human mtDNA replisome is composed of the DNA helicase Twinkle, DNA polymerase...

Full description

Bibliographic Details
Main Authors: Joon Park, Noe Baruch-Torres, Y. Whitney Yin
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/4/1796
_version_ 1797619025884217344
author Joon Park
Noe Baruch-Torres
Y. Whitney Yin
author_facet Joon Park
Noe Baruch-Torres
Y. Whitney Yin
author_sort Joon Park
collection DOAJ
description Human mitochondrial DNA (mtDNA) is a 16.9 kbp double-stranded, circular DNA, encoding subunits of the oxidative phosphorylation electron transfer chain and essential RNAs for mitochondrial protein translation. The minimal human mtDNA replisome is composed of the DNA helicase Twinkle, DNA polymerase γ, and mitochondrial single-stranded DNA-binding protein. While the mitochondrial RNA transcription is carried out by mitochondrial RNA polymerase, mitochondrial transcription factors TFAM and TFB2M, and a transcription elongation factor, TEFM, both RNA transcriptions, and DNA replication machineries are intertwined and control mtDNA copy numbers, cellular energy supplies, and cellular metabolism. In this review, we discuss the mechanisms governing these main pathways and the mtDNA diseases that arise from mutations in transcription and replication machineries from a structural point of view. We also address the adverse effect of antiviral drugs mediated by mitochondrial DNA and RNA polymerases as well as possible structural approaches to develop nucleoside reverse transcriptase inhibitor and ribonucleosides analogs with reduced toxicity.
first_indexed 2024-03-11T08:21:06Z
format Article
id doaj.art-8094e99a01ed46d5b0f93c3474e838e0
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-11T08:21:06Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-8094e99a01ed46d5b0f93c3474e838e02023-11-16T22:23:19ZengMDPI AGMolecules1420-30492023-02-01284179610.3390/molecules28041796Structural and Molecular Basis for Mitochondrial DNA Replication and Transcription in Health and Antiviral Drug ToxicityJoon Park0Noe Baruch-Torres1Y. Whitney Yin2Department of Biochemistry and Molecular Biology, Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Biochemistry and Molecular Biology, Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Biochemistry and Molecular Biology, Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, TX 77555, USAHuman mitochondrial DNA (mtDNA) is a 16.9 kbp double-stranded, circular DNA, encoding subunits of the oxidative phosphorylation electron transfer chain and essential RNAs for mitochondrial protein translation. The minimal human mtDNA replisome is composed of the DNA helicase Twinkle, DNA polymerase γ, and mitochondrial single-stranded DNA-binding protein. While the mitochondrial RNA transcription is carried out by mitochondrial RNA polymerase, mitochondrial transcription factors TFAM and TFB2M, and a transcription elongation factor, TEFM, both RNA transcriptions, and DNA replication machineries are intertwined and control mtDNA copy numbers, cellular energy supplies, and cellular metabolism. In this review, we discuss the mechanisms governing these main pathways and the mtDNA diseases that arise from mutations in transcription and replication machineries from a structural point of view. We also address the adverse effect of antiviral drugs mediated by mitochondrial DNA and RNA polymerases as well as possible structural approaches to develop nucleoside reverse transcriptase inhibitor and ribonucleosides analogs with reduced toxicity.https://www.mdpi.com/1420-3049/28/4/1796mitochondriaDNA replicationRNA transcriptionhuman diseasesantiviralsHIV
spellingShingle Joon Park
Noe Baruch-Torres
Y. Whitney Yin
Structural and Molecular Basis for Mitochondrial DNA Replication and Transcription in Health and Antiviral Drug Toxicity
Molecules
mitochondria
DNA replication
RNA transcription
human diseases
antivirals
HIV
title Structural and Molecular Basis for Mitochondrial DNA Replication and Transcription in Health and Antiviral Drug Toxicity
title_full Structural and Molecular Basis for Mitochondrial DNA Replication and Transcription in Health and Antiviral Drug Toxicity
title_fullStr Structural and Molecular Basis for Mitochondrial DNA Replication and Transcription in Health and Antiviral Drug Toxicity
title_full_unstemmed Structural and Molecular Basis for Mitochondrial DNA Replication and Transcription in Health and Antiviral Drug Toxicity
title_short Structural and Molecular Basis for Mitochondrial DNA Replication and Transcription in Health and Antiviral Drug Toxicity
title_sort structural and molecular basis for mitochondrial dna replication and transcription in health and antiviral drug toxicity
topic mitochondria
DNA replication
RNA transcription
human diseases
antivirals
HIV
url https://www.mdpi.com/1420-3049/28/4/1796
work_keys_str_mv AT joonpark structuralandmolecularbasisformitochondrialdnareplicationandtranscriptioninhealthandantiviraldrugtoxicity
AT noebaruchtorres structuralandmolecularbasisformitochondrialdnareplicationandtranscriptioninhealthandantiviraldrugtoxicity
AT ywhitneyyin structuralandmolecularbasisformitochondrialdnareplicationandtranscriptioninhealthandantiviraldrugtoxicity